Literature DB >> 7057488

Digital subtraction angiography for postoperative evaluation of renal arterial reconstruction.

A C Novick, E Buonocore, T F Meaney.   

Abstract

Digital subtraction angiography after peripheral intravenous injection of contrast material is a new method to evaluate the cardiovascular system. Digital subtraction angiography was obtained postoperatively in 21 patients undergoing renal revascularization for treatment of hypertension and/or preservation of renal function. Digital subtraction angiography provided excellent visualization of the reconstructed renal arterial supply in all cases. The advantages and limitations of this technique in the evaluation of patients with renovascular disorders are discussed.

Entities:  

Mesh:

Year:  1982        PMID: 7057488     DOI: 10.1016/s0022-5347(17)53576-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Renal digital subtraction angiography.

Authors:  D P Harrington
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

2.  Current experience with digital subtraction angiography in the community medical center.

Authors:  S J Hessel; J M Levy; J K Crowe; P W Nykamp; R M Spiegel; C J Stegman; W W Horsley
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

3.  Digital intravenous angiography in the diagnosis of renal artery occlusion.

Authors:  C Beinart; S Saddekni; T A Sos; K W Sniderman; M A Weiner
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

4.  Digital intravenous subtraction angiography in the evaluation of reconstructed renal arteries.

Authors:  M Saeed; S D Braun; F F Illescas; S K Sussman; R L McCann; N R Dunnick
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

5.  Use of the hepatic circulation for renal revascularization.

Authors:  E A Chibaro; J A Libertino; A C Novick
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.